Abstract:Introduction The Clock Draw Test (CDT) is a common cognitive screening test that is known to be impacted by education and culture. Multiple studies have demonstrated the strengths of this easily administered and time efficient metric, but there is limited literature on how and why psychiatrists choose to use the CDT and how it informs their clinical decision making. We sought to explore if clinical specialization (consult liaison/geriatrics) versus non-specialization (general adult psychiatry) was associated with CDT use, and to describe psychiatrists’ feelings and beliefs about the CDT. Methods 52 psychiatrists, 62% of whom reported advanced training and board certification in either consult liaison (N=27) or geriatric (N=5) psychiatry completed a Survey Monkey questionnaire that was distributed to psychiatrists at two academic institutions (one in NY and one in CA), and to the New York Branch of the Society of Consult Liaison listserv. The majority practiced in an urban environment (90.38%) and their clinical setting was in an inpatient hospital (32.69%) or outpatient setting (40.38%). Years of clinical practice ranged from 1 to 30 plus years and most were between the ages of 35-45 years (36.54%). 34.62% of respondents see 10-20 patients per week and 36.54% see 20-30 patients per week. Given the small number of geriatric psychiatrists who completed the survey, the C/L and geriatric psychiatry groups were combined into “specialized psychiatrists” for analysis. Descriptive analysis and independent sample x2 test of association were computed using Jamovi. Results Specialized psychiatrists reported administering CDT more frequently (p=0.009), being more confident in interpreting CDT (p=0.017), and using a formal grading system more frequently (p=0.027) than general psychiatrists. There was no statistical difference between the two groups of psychiatrists in how often they used the CDT to track cognitive changes or to ask patients if they noticed cognitive changes, obtained collateral, did a medication reconciliation, ordered reversible causes of dementia labs, ordered head imaging, ordered a neurology consult, and or provided patients with dementia resources. There was also no statistical difference between fellowship boarded psychiatrists and general adult psychiatrists in terms of if they think education or employment history impacts clock drawing abilities. About half of the psychiatrist surveyed believed that education impacts CDT performance and about 27% believed that employment history impacts CDT performance. Conclusions In this convenience sample of primarily urban psychiatrists in academic centers we found that although general psychiatrists were just as likely to act on atypical CDT as a specialized psychiatrist, those with advanced training were more likely to complete a CDT with their patient and use a formal scoring system. Not surprisingly, specialized psychiatrists also felt more confident in their CDT administration which may lead to increased CDT administration or may be secondary to increased CDT administration. Early detection tests are important as they can add valuable information in a short amount of time and can guide treatment steps. We hope to encourage clinicians to consider possible treatment plans that are informed by this test. The findings of this project will be used to improve the care of patients with dementia as well as provide preliminary data for future studies. Limitations of this study include small sample size and wording of some of the survey questions.

Estimating dementia risk in an African American population using the DCTclock

Digitized Biomarkers Utilizing Human‐Computer Interaction Sensing Technology for Early Auxiliary Diagnosis of Alzheimer’s Disease

Extended Application of Digital Clock Drawing Test in the Evaluation of Alzheimer's Disease Based on Artificial Intelligence and the Neural Basis

DCTclock: Clinically-Interpretable and Automated Artificial Intelligence Analysis of Drawing Behavior for Capturing Cognition

DIGITAL CLOCK DRAWING PERFORMANCE ASSOCIATIONS WITH ALZHEIMER’S DISEASE GENETIC RISK SCORE AND APOE IN OLDER ADULTS

The utility of the digital clock drawing test as an accurate early screening tool for those with preclinical Alzheimer’s disease

An Artificial Intelligence-Assisted Method for Dementia Detection Using Images from the Clock Drawing Test

Digital Clock and Recall: a digital, process-driven evolution of the Mini-Cog

An AI-assisted Online Tool for Cognitive Impairment Detection Using Images from the Clock Drawing Test

A Survey of How Clock Draws Influence Clinical Practice

Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia

Cerebral Microbleeds in Different Brain Regions and Their Associations With the Digital Clock-Drawing Test: Secondary Analysis of the Framingham Heart Study

Application of Clock Drawing Test in Evaluating Different Types of Dementias (Alzheimer’s Disease, Vascular Dementia and Fronto-temporal Dementia): A Cross-sectional Observational Study

Dcdt: A Digital Clock Drawing Test System For Cognitive Impairment Screening

Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.

External validation of dementia prediction models in Black or African American and White older adults: A longitudinal population‐based study in the United States

Longitudinal Changes In Clock Drawing Test (Cdt) Performance Before And After Cognitive Decline

Association of DNA methylation age acceleration with digital clock drawing test performance: the Framingham Heart Study

Prognostic value of cognitive impairment, assessed by the Clock Drawing Test, in emergency department patients presenting with non-specific complaints

The Value of Clock Drawing Process Assessment in Screening for Mild Cognitive Impairment and Alzheimer's Dementia

Individualized, cross‐validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms